Thomas S. Mchugh - Jan 16, 2024 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role
Chief Financial Officer
Signature
/s/ Jerad G. Seurer, Attorney-in-Fact
Stock symbol
AVDL
Transactions as of
Jan 16, 2024
Transactions value $
$29,000
Form type
4
Date filed
1/16/2024, 04:36 PM
Previous filing
Aug 14, 2023
Next filing
Mar 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVDL ADSs Purchase $29K +2K +2.55% $14.50 80.5K Jan 16, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the Issuer; ADSs may be represented by American Depositary Receipts.